The Use of Nanobiotechnology in Immunology and Vaccination
Open Access
Abstract
Nanotechnology uses the unique properties of nanostructures with a size of 1 to 200 nanometers. Different nanoparticles have shown great promise for the production of new vaccines and drugs. Nanostructures can be used to deliver immunological compounds more effectively than microstructures to target sites. Different nanostructures can be applied to form a new generation of vaccines, adjuvants, and immune system drugs. The goal of nanotechnology is to better respond to a wide range of infectious and non-infectious diseases.Keywords
This publication has 63 references indexed in Scilit:
- Nanoparticle-Based Vaccine Delivery for Cancer ImmunotherapyImmune Network, 2013
- Nano‐particle vaccination combined with TLR‐7 and ‐9 ligands triggers memory and effector CD8+T‐cell responses in melanoma patientsEuropean Journal of Immunology, 2012
- MF59™ as a vaccine adjuvant: a review of safety and immunogenicityExpert Review of Vaccines, 2010
- Minireview: Nanoparticles and the Immune SystemEndocrinology, 2010
- Current advances in research and clinical applications of PLGA-based nanotechnologyExpert Review of Molecular Diagnostics, 2009
- Emulsion-based adjuvants for influenza vaccinesExpert Review of Vaccines, 2009
- Virus-like Particle (VLP) Lymphatic Trafficking and Immune Response Generation After Immunization by Different RoutesJournal of Immunotherapy, 2009
- Synthetic Virus‐Like Particles from Self‐Assembling Coiled‐Coil Lipopeptides and Their Use in Antigen Display to the Immune SystemAngewandte Chemie International Edition, 2007
- Incorporation of High Levels of Chimeric Human Immunodeficiency Virus Envelope Glycoproteins into Virus-Like ParticlesJournal of Virology, 2007
- Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogenVaccine, 2004